Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
WithdrawnNot applicableNCT03498014
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators hypothesize that opioid prescription guided by patient pharmacogenetic profile will diminish opioid-associated undesirable effects by 50% and improve medication compliance.
Study details
- Official title
- Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
- Conditions
- Non-cancerous Chronic Pain
- Interventions
- Other: Pharmacogenetic analysis allowing personalized opioid prescription
- Other: Standard opioid prescription
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Start date
- 2022-07
- Primary completion
- 2023-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * The patient is at least 18 years old * The patient will be available for all visits * Patients suffer from non-cancerous chronic pain according to HAS criteria * Patient not having taking opioids in previous 2 months * Patient indicated for prescription of opioids (oxycodone, codeine or tramadol) or patient not responding to first line treatment Exclusion Criteria: * The subject is participating in an category I interventional study, or is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * The patient is pregnant or breastfeeding * The patient is likely to procreate and does not use an effective method of contraception (contraceptive ring, surgical contraception, implant, patch, contraceptive pill, male and female condoms, IUD) * There is a contra-indication for opioid use * Patient with an addiction risk (score ≥ 8 on ORT scale).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03498014